Ülke: Birleşik Krallık
Dil: İngilizce
Kaynak: VMD (Veterinary Medicines Directorate)
Tylosin
Cross Vetpharm Group Ltd
QJ01FA90
Tylosin
Solution for injection
POM-V - Prescription Only Medicine – Veterinarian
Cattle, Pigs
Antimicrobial
Authorized
2014-12-22
Revised: March 2018 Amended pages SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Bilovet 200 mg/ml Solution for Injection for cattle and pigs - UK, IE, BE, DE, IT, NL, ES, RO 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Per ml: ACTIVE SUBSTANCE: Tylosin 200 mg (equivalent to 200,000 IU/ml) EXCIPIENT: Benzyl alcohol 41.66 mg For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for Injection. Clear, yellow aqueous solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle and pigs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Infections caused by microorganisms susceptible to tylosin. Cattle (adult): - Treatment of respiratory infections, metritis caused by Gram-positive micro- organisms, mastitis caused by _Streptococcus _spp., _Staphylococcus _spp. and interdigital necrobacillosis, caused by _Fusobacterium necrophorum_ , i.e. panaritum or foot rot. Calves: - Treatment of respiratory infections and necrobacillosis (calf diphtheria cause by _Fusobacterium necrophorum)_. Pigs: - Treatment of enzootic pneumonia caused by _Mycoplasma hyopneumoniae_,, haemorrhagic enteritis, (Porcine proliferative haemorrhagic enteropathy due to _Lawsonia intracellularis_) erysipelas caused by _Erysipelothrix rhusiopathiae _and metritis. - Treatment of arthritis caused by _Mycoplasma _and _Staphylococcus _spp. Page 1 of 5 Revised: March 2018 Amended pages 4.3 CONTRAINDICATIONS The product should not be given to chickens or turkeys. Do not administer to horses or other equines in which injection of tylosin may be fatal. Do not administer to animals with known hypersensitivity to tylosin, other macrolides or any of the excipients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should be based on local epidemiological information. For administration by the intra Belgenin tamamını okuyun